No data to show
OTCM
HLTHQ
Market cap0kUSD
Mar 24, Last price
0.00USD
1D
0.00%
1Q
0.00%
IPO
-100.00%
Name
Cue Health Inc
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
71m
-85.33%
Net income
-373m
L+92.45%
CFO
-138m
L+23.13%
Profile
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 70,936 -85.33% | 483,476 -21.78% | |||
Cost of revenue | 367,650 | 687,108 | |||
Unusual Expense (Income) | |||||
NOPBT | (296,714) | (203,632) | |||
NOPBT Margin | |||||
Operating Taxes | 4,793 | (9,748) | |||
Tax Rate | |||||
NOPAT | (301,507) | (193,884) | |||
Net income | (373,464) 92.45% | (194,056) -324.56% | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 113 | (4,216) | |||
BB yield | -0.45% | 1.38% | |||
| Debt | |||||
Debt current | 6,299 | 10,101 | |||
Long-term debt | 83,280 | 99,889 | |||
Deferred revenue | |||||
Other long-term liabilities | 4,429 | 1,997 | |||
Net debt | 7,890 | (131,540) | |||
| Cash flow | |||||
Cash from operating activities | (137,811) | (111,919) | |||
CAPEX | (19,799) | (63,031) | |||
Cash from investing activities | (19,799) | (63,031) | |||
Cash from financing activities | (3,031) | (6,430) | |||
FCF | (125,525) | (220,296) | |||
| Balance | |||||
Cash | 81,689 | 241,530 | |||
Long term investments | |||||
Excess cash | 78,142 | 217,356 | |||
Stockholders' equity | (591,536) | (218,073) | |||
Invested Capital | 894,156 | 850,198 | |||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 152,877 | 148,025 | |||
Price | 0.16 -92.15% | 2.07 -84.56% | |||
Market cap | 24,843 -91.89% | 306,411 -84.39% | |||
EV | 32,733 | 174,871 | |||
EBITDA | (240,436) | (158,690) | |||
EV/EBITDA | |||||
Interest | 1,159 | 645 | |||
Interest/NOPBT | |||||